Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016

Enferm Infecc Microbiol Clin. 2017 Jun-Jul;35(6):377-383. doi: 10.1016/j.eimc.2016.11.016. Epub 2017 Feb 22.
[Article in English, Spanish]

Abstract

Administration of antiretroviral drugs to individuals exposed to, but not infected by, HIV has been shown to reduce the risk of transmission. The efficacy of pre-exposure prophylaxis (PrEP) makes it obligatory to include it in an integral program of prevention of HIV transmission, together with other measures, such as use of the condom, training, counseling, and appropriate treatment of infected individuals. In this document, the AIDS Study Group (GeSIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica [SEIMC]) provides its views on this important subject. The available evidence on the usefulness of PrEP in the prevention of transmission of HIV is presented, and the components that should make up a PrEP program and whose development and implementation are feasible in Spain are set out.

Keywords: HIV infection; Infección por VIH; Pre-exposure prophylaxis; Prevención; Prevention; Profilaxis pre-exposición; Tenofovir.

Publication types

  • Practice Guideline

MeSH terms

  • Adult
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / therapeutic use
  • Comorbidity
  • Counseling
  • Female
  • HIV Infections / epidemiology
  • HIV Infections / prevention & control*
  • Humans
  • Infectious Disease Medicine
  • Male
  • Microbiology
  • Outpatient Clinics, Hospital
  • Pre-Exposure Prophylaxis / methods
  • Pre-Exposure Prophylaxis / standards*
  • Pregnancy
  • Pregnancy Complications, Infectious / epidemiology
  • Pregnancy Complications, Infectious / prevention & control
  • Pregnancy Complications, Infectious / virology
  • Prevalence
  • Risk Factors
  • Risk-Taking
  • Societies, Medical / standards
  • Spain / epidemiology

Substances

  • Anti-HIV Agents